A hybrid machine learning approach for the personalized prognostication of aggressive skin cancers by Tom W. Andrew, Mogdad Alrawi, Ruth Plummer, Nick Reynolds, Vern Sondak, Isaac Brownell, Penny E. Lovat, Aidan Rose, Sophia Z. Shalhout

Get full text

Targeting the DNA double strand break repair machinery in prostate cancer. by Fadhel S Shaheen, Pawel Znojek, Ann Fisher, Martin Webster, Ruth Plummer, Luke Gaughan, Graeme C M Smith, Hing Y Leung, Nicola J Curtin, Craig N Robson

Get full text

CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study by Omid Hamid, Fiona Thistlethwaite, Johanna Bendell, Ruth Plummer, Patrick A Ott, Rachel E Sanborn, Karen A Autio, Valentina Boni, Elisabeth GE de Vries, Javier Garcia-Corbacho, Daniel C Cho, Mark Stroh, Lawrence Lu

Get full text